George Tweddel, MD
Obstetrics & Gynecology · Warren, NJNPI 1013928647
Payments from drug & device makers
Across 87 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celularity Inc.$316
- Medtronic$241
- Astellas Pharma US Inc$130
- Hologic Sales And Service, LLC$117
- Sumitomo Pharma America, Inc.$112
- AbbVie$105
- plus $814 from 21 others
What the payments were for
- Speaking & faculty fees$30016%
- Food & beverage$1,44979%
- Education$865%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celularity Inc. | 2 | $316 |
| Medtronic | 6 | $241 |
| Astellas Pharma US Inc | 6 | $130 |
| Hologic Sales And Service, LLC | 6 | $117 |
| Sumitomo Pharma America, Inc. | 7 | $112 |
| AbbVie(2 entities) | 7 | $105 |
| AMAG Pharmaceuticals, Inc. | 6 | $86 |
| Mayne Pharma Commercial LLC | 6 | $81 |
| Evofem Biosciences, Inc. | 5 | $77 |
| Bayer | 3 | $74 |
| Daiichi Sankyo Inc. | 5 | $73 |
| Therapeuticsmd, Inc. | 4 | $56 |
| Pfizer | 3 | $47 |
| Avion Pharmaceuticals | 3 | $40 |
| Alydia Health | 1 | $33 |
| Myovant Sciences Inc. | 2 | $32 |
| Coopersurgical, Inc. | 2 | $31 |
| Exeltis, USA Inc. | 2 | $29 |
| Novo Nordisk | 2 | $27 |
| Millicent US Inc | 2 | $25 |
| Lilly USA, LLC | 1 | $18 |
| Merck | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Amgen | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Minerva Surgical, Inc | 1 | $11 |
How this compares
$1,835 in reported general payments places this provider in the 75th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 50 | $3,191 |
| DottiEstradiol | 18 | $1,453 |
| ProgesteroneProgesterone, Micronized | 13 | $469 |
| Ibandronate Sodium | 14 | $336 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Warren
- Jennifer AshtonEnglewood$1.5M
- Gregory HirschMorristown$1.3M
- Steven SussmanLawrenceville$623K
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Justin ChuraSwedesboro$193K
- Paula JasionowskiVoorhees$193K
- Peter ChenSewell$191K
- Andrea VentolaFlorham Park$145K
- Kristy PalomaresNew Brunswick$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.